| Group 2 innate lymphoid cells (ILC 2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia J Ho, M Bailey, J Zaunders, N Mrad, R Sacks, W Sewell, RJ Harvey Clinical & Experimental Allergy 45 (2), 394-403, 2015 | 187 | 2015 |
| Systemic predictors of eosinophilic chronic rhinosinusitis J Ho, AW Hamizan, R Alvarado, J Rimmer, WA Sewell, RJ Harvey American journal of rhinology & allergy 32 (4), 252-257, 2018 | 108 | 2018 |
| Allergic phenotype of chronic rhinosinusitis based on radiologic pattern of disease AW Hamizan, PA Loftus, R Alvarado, J Ho, L Kalish, R Sacks, ... The Laryngoscope 128 (9), 2015-2021, 2018 | 73 | 2018 |
| Cellular comparison of sinus mucosa vs polyp tissue from a single sinus cavity in chronic rhinosinusitis J Ho, M Bailey, J Zaunders, N Mrad, R Sacks, W Sewell, RJ Harvey International forum of allergy & rhinology 5 (1), 14-27, 2015 | 43 | 2015 |
| Systemic biomarkers of eosinophilic chronic rhinosinusitis J Ho, P Earls, RJ Harvey Current Opinion in Allergy and Clinical Immunology 20 (1), 23-29, 2020 | 42 | 2020 |
| Periostin as a marker of mucosal remodelling in chronic rhinosinusitis JA Ebenezer, JM Christensen, BG Oliver, RA Oliver, G Tjin, J Ho, ... Rhinology 55 (3), 234-241, 2017 | 39 | 2017 |
| Atopy in chronic rhinosinusitis: impact on quality of life outcomes J Ho, R Alvarado, J Rimmer, WA Sewell, RJ Harvey International forum of allergy & rhinology 9 (5), 501-507, 2019 | 31 | 2019 |
| Systemic medication requirement in post-surgical patients with eosinophilic chronic rhinosinusitis. J Ho, W Li, JW Grayson, R Alvarado, J Rimmer, WA Sewell, RJ Harvey Rhinology 59 (1), 59-65, 2021 | 21 | 2021 |
| Topography of polyp recurrence in eosinophilic chronic rhinosinusitis JW Grayson, W Li, J Ho, R Alvarado, J Rimmer, WA Sewell, RJ Harvey International Forum of Allergy & Rhinology 10 (5), 604-609, 2020 | 21 | 2020 |
| Evaluation of diffuse type 2 dominant or eosinophilic chronic rhinosinusitis with corticosteroid irrigation after surgical neosinus cavity formation W Li, J Ho, JW Grayson, R Alvarado, J Rimmer, WA Sewell, R Campbell, ... JAMA Otolaryngology–Head & Neck Surgery 147 (4), 360-367, 2021 | 17 | 2021 |
| Mepolizumab decreases tissue eosinophils while increasing type‐2 cytokines in eosinophilic chronic rhinosinusitis S Walter, J Ho, R Alvarado, G Smith, DR Croucher, S Liang, JW Grayson, ... Clinical & Experimental Allergy 52 (12), 1403-1413, 2022 | 15 | 2022 |
| Sinus radiological findings in general asymptomatic populations: a systematic review of incidental mucosal changes B Razi, A Perkovic, R Alvarado, A Stroud, J Ho, LH Kalish, RG Campbell, ... Otolaryngology–Head and Neck Surgery 167 (1), 16-24, 2022 | 14 | 2022 |
| Effect of monoclonal antibody drug therapy on mucosal biomarkers in airway disease: A systematic review S Walter, J Ho, R Alvarado, J Rimmer, R Campbell, L Kalish, R Sacks, ... Clinical & Experimental Allergy 50 (11), 1212-1222, 2020 | 11 | 2020 |
| Comparison of sinonasal histopathological changes in biological treatment of eosinophilic chronic rhinosinusitis J Ho, R Alvarado, J Rimmer, WA Sewell, S Walter, P Earls, RG Campbell, ... American Journal of Rhinology & Allergy 36 (1), 72-80, 2022 | 7 | 2022 |
| Eosinophilic chronic rhinosinusitis and concurrent Kimura’s disease treated with mepolizumab J Ho, S Walter, RJ Harvey BMJ Case Reports CP 14 (1), e232627, 2021 | 7 | 2021 |
| Age of presentation as a distinguishing feature between persistent rhinitis and chronic rhinosinusitis. A Perkovic, J Ho, D Kanjanawasee, R Alvarado, J Rimmer, LH Kalish, ... International Forum of Allergy & Rhinology 12 (2), 2022 | 2 | 2022 |
